伊马替尼在住院COVID-19患者的短期和长期影响:一个随机试验
Alex L E Halme1, Sanna Laakkonen1, Jarno Rutanen2
1Faculty of Medicine, University of Helsinki, Helsinki, Finland.
The Journal of infection
|July 5, 2024
概括
这项研究没有发现imaatinib在降低死亡率或改善住院COVID-19患者的康复方面有明显的益处. 需要进一步的研究来澄清 imatinib.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 住院COVID-19患者面临显著的短期和长期风险.
- 伊马替尼 (imatinib) 是一种氨酸激酶抑制剂,其潜在的抗病毒和抗炎性质已被研究.
研究的目的:
- 评估伊马蒂尼布在住院COVID-19患者的短期和长期影响.
- 评估伊马替尼对死亡率,康复,生活质量和长期COVID症状的影响.
主要方法:
- 随机对照试验比较标准护理 (SoC) 与SoC加伊马替尼布 (每天400毫克).
- 主要结局:30天和1年死亡率.
- 二次结果:1年后的康复,生活质量和长期COVID症状.
- 对伊马替尼布随机试验的系统审查和元分析,用于COVID-19中30天死亡率.
主要成果:
- 156名患者随机选择 (73名SoC,83名伊马替尼).
- 30天死亡率:7.2% (imatinib) 与4.1% (SoC) 相比. 一年死亡率:13.3% (imatinib) 与8.2% (SoC) 相比.
- 一年恢复:79.0% (伊马提尼布) 与88.5% (SoC) 相比. 生活质量或症状没有显著差异.
- 分析显示死亡风险比率为0.73 (低确定性证据).
结论:
- 证据表明,伊马替尼不显著降低死亡率或改善住院COVID-19患者的康复.
- 伊马替尼布在预防长期COVID症状方面没有表现出有效性.
- 需要进一步调查以澄清伊马替尼在COVID-19管理中的作用.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K